Interferon-beta-1a treatment increases CD56bright natural killer cells and CD4+CD25+ Foxp3 expression in subjects with multiple sclerosis.

Source:http://linkedlifedata.com/resource/pubmed/id/19758707

J. Neuroimmunol. 2009 Oct 30 215 1-2 125-8

Download in:

View as

General Info

PMID
19758707